Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent. Results of a phase III Multicenter Trial.
暂无分享,去创建一个
D S Segar | J. Gottdiener | L. Gillam | D. Segar | J. Cheirif | J L Cohen | L D Gillam | J. Cohen | J S Gottdiener | J Cheirif | E Hausnerova | D E Bruns | E. Hausnerova | Jerald L. Cohen | D. E. Bruns
[1] S. Kaul,et al. Albunex: a safe and effective commercially produced agent for myocardial contrast echocardiography. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[2] J. T. Thompson,et al. Prediction of the kinetics of disappearance of sulfur hexafluoride and perfluoropropane intraocular gas bubbles. , 1988, Ophthalmology.
[3] S. Feinstein,et al. Reduced forward output states affect the left ventricular opacification of intravenously administered Albunex. , 1997, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[4] K. A. Robinson,et al. Effects of left ventricular pressure on sonicated albumin microbubbles: evaluation using an isolated rabbit heart model. , 1994, Journal of the American College of Cardiology.
[5] T. Skotland,et al. Physical and biochemical characterization of Albunex, a new ultrasound contrast agent consisting of air‐filled albumin microspheres suspended in a solution of human albumin , 1994, Biotechnology and applied biochemistry.
[6] P. Burns. Harmonic imaging with ultrasound contrast agents. , 1996, Clinical radiology.
[7] J. Kisslo,et al. Opacification and border delineation improvement in patients with suboptimal endocardial border definition in routine echocardiography: results of the Phase III Albunex Multicenter Trial. , 1991, Journal of the American College of Cardiology.
[8] R. Mattrey. The potential role of perfluorochemicals (PFCs) in diagnostic imaging. , 1994, Artificial cells, blood substitutes, and immobilization biotechnology.
[9] R. Thisted,et al. The influence of intravenous Albunex injections on pulmonary arterial pressure, gas exchange, and left ventricular peak intensity. , 1992, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[10] K. A. Robinson,et al. Echocardiographic contrast agents and left ventricular contractility: evaluation using an isolated rabbit heart model. , 1996, Journal of the American Society of Echocardiography.
[11] Chilton,et al. Pharmaceuticals in Medical Imaging , 1990 .
[12] F J Ten Cate,et al. Safety and efficacy of a new transpulmonary ultrasound contrast agent: initial multicenter clinical results. , 1990, Journal of the American College of Cardiology.
[13] J. Kisslo,et al. Contrast echocardiography: influence of ultrasonic machine settings, mixing conditions, and pressurization on pixel intensity and microsphere size of Albunex solutions in vitro. , 1997, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[14] S. Feinstein,et al. Loss of contrast intensity during systole in the left ventricular cavity with the use of the contrast agent Albunex. An analysis of its correlation with pressure and velocity. , 1996, Investigative radiology.
[15] S. Feinstein,et al. Pitfalls in quantitative contrast echocardiography: the steps to quantitation of perfusion. , 1993, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[16] S. Kaul,et al. Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection. , 1996, Journal of the American College of Cardiology.
[17] A. Weyman,et al. Effect of static pressure on the disappearance rate of specific echocardiographic contrast agents. , 1994, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[18] J. Murgo,et al. Myocardial contrast echocardiography: reliable, safe, and efficacious myocardial perfusion assessment after intravenous injections of a new echocardiographic contrast agent. , 1996, American heart journal.
[19] F. Piquard,et al. Safety and efficacy of a new transpulmonary echo contrast agent in echocardiographic studies in patients. , 1993, Journal of the American College of Cardiology.
[20] S. Kaul,et al. Interactions between microbubbles and ultrasound: in vitro and in vivo observations. , 1997, Journal of the American College of Cardiology.
[21] Arnold B. Arons,et al. Underwater Acoustics Handbook II , 1966 .
[22] R. Erbel,et al. The influence of Albunex on the pulmonary circulation in patients with pulmonary hypertension or left heart failure. , 1996, European heart journal.